EFFICACY AND SAFETY OF SUBLINGUAL MISOPROSTOL IN REDUCING INTRAOPERATIVE BLOOD LOSS DURING ABDOMINAL MYOMECTOMY
DOI:
https://doi.org/10.52764/jms.26.34.1.2Abstract
Objective: To compare the effectiveness and safety of 400 mg of sublingual and per rectal Misoprostol when given 1 hour prior to abdominal Myomectomy in reducing intraoperative blood loss.
Material and Methods: A quasi-experimental study involving women with uterine leiomyoma was conducted at Khyber Teaching Hospital, Peshawar, Pakistan, including patients who underwent abdominal myomectomy. Participants were enrolled after providing informed consent and were randomly assigned to either group 1, which received 400 mg of misoprostol rectally, or group II, which received 400 mg of misoprostol sublingually one hour before surgery. A total of 48 participants were enrolled. The primary outcome measures were intraoperative blood loss and the difference between preoperative and postoperative hemoglobin levels; secondary measures included postoperative febrile morbidity, gastrointestinal complaints, and other side effects. All data were stored and analyzed using SPSS 20. A p-value of <0.05 was considered statistically significant.
Results: The mean age of patients in group 1 (per rectal) was 32.6 (± 4.8) years, and in group 2 (sublingual) it was 33.8 (± 4.5) years. The mean parity in group 1 was 1.8 (1.3), while in group 2 it was 1.3 (1.2). The mean uterine size in group 1 was 17.6 (2.3) cm, and in the per rectal group, 15.8 (2.2) cm. Blood loss during the myomectomy procedure was 342.8 (154.6) ml in group 1 and 386.5 (118.3) ml in the sublingual group. Complications of misoprostol were very rare and minor, such as nausea and uterine cramps.
Conclusion: Sublingual misoprostol is an effective and safe agent for reducing blood loss during abdominal myomectomy. When compared with the use of the same dose of per rectal misoprostol given 1 hour before surgery, it did not show a significant difference; however, the ease of administration via the sublingual route is favored and acceptable to women in the Asian community.
Keywords: Sublingual Misoprostol, Intraoperative Blood Loss, Myomectomy
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Tayaba Mazhar, Mahjabina S Ghayur, Zeenat Adil, Ambreen Haris
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.
